(Q38794097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

review article

1 reference

title

Established and novel treatment options in acute myocarditis, with or without heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

George Lazaros

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

1 reference

23 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Cardiovascular Therapy

27 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

25-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

27 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoraci

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Betablockers for haemodynamically stable acute myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

Update on myocarditis

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

Fulminant myocarditis

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

A case report of eosinophilic myocarditis and a review of the relevant literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Acute cytomegalovirus infection triggering fatal giant cell myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Long-term outcome and its predictors in giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Combined immunosuppression for the treatment of idiopathic giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Effect of metoprolol in acute coxsackievirus B3 murine myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Anti-inflammatory effects of eplerenone on viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

Acute viral myocarditis

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Comparative effects of pranidipine with amlodipine in rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Nifedipine inhibits the activation of inflammatory and immune reactions in viral myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Diagnosis and treatment of myocarditis in children in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Enhancement of Coxsackievirus B3 replication in Vero cells by indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Management of myopericarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Diagnosis and management of cardiac sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

The subcutaneous defibrillator: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Endomyocardial biopsy in new onset dilated cardiomyopathy: prevalence and prognostic role of infectious agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Viral myocarditis--diagnosis, treatment options, and current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Pathogen-driven treatment strategy in new onset dilated cardiomyopathy. Impact on ventricular function and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

The management of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

How to approach the great mimic? Improving techniques for the diagnosis of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Recurrent pericarditis: new and emerging therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Cochrane Database of Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Improving outcomes of acute myocarditis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Immunoadsorption therapy in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Autoimmunity in myocarditis: relevance of animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Emerging treatments for viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Emerging pharmacologic targets and treatments for myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

The Epidemiology of Childhood Cardiomyopathy in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

The natural history and role of immunoadsorption in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Myocarditis and dilated cardiomyopathy in athletes: diagnosis, management, and recommendations for sport activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Recurrent coxsackie B viral myocarditis leading to progressive impairment of left ventricular function over 8years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14779072.2017.1262764

10.1080/14779072.2017.1262764

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27858465%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference